Stock listing

Frankfurt:272 Mabion SA Aktie

German listing (Frankfurt) of Mabion SA · home listing GPW:MAB

Follow Mabion SA into a list and get an email when it puts out news.

Share price · FWB:272

€2.02 EUR -0.02 (-1.0%)

Close on Nov 20, 2026

Past year +39.9% · daily closes, Nov 20, 2025 – Nov 13, 2026, adjusted for splits
Day range
€2.02 – €2.02 EURNov 20, 2026
Market cap
€32.57M EURAt the close on Nov 20, 2026 · price × 16.16M shares outstanding
52-week range
€1.57 – €2.48 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€0 EURMedian day 0 shares · 62 days with no trades · last 3 months, Aug 20, 2026 – Nov 13, 2026
Mabion SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
GPW:MAB · Home8.90 PLN-0.54 (-5.7%)77,6579.229.388.889.44Close on Nov 20, 2026
Frankfurt:272€2.015 EUR-0.02 (-1.0%)—€2.015€2.015€2.015€2.035Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 13, 2026 · FWB:272 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.467+0.776+45.9%€2.183€2.479€2.1660
€1.691+0.021+1.3%€1.691€1.691€1.6910
€1.67-0.001-0.1%€1.67€1.67€1.670
€1.6710.000.0%€1.671€1.671€1.6710
€1.671-0.008-0.5%€1.671€1.671€1.6710
€1.679-0.03-1.8%€1.679€1.679€1.6790
€1.709+0.014+0.8%€1.709€1.709€1.7090
€1.695+0.009+0.5%€1.695€1.695€1.6950
€1.686-0.031-1.8%€1.686€1.686€1.6860
€1.717-0.009-0.5%€1.717€1.717€1.7170
€1.726+0.012+0.7%€1.726€1.726€1.7260
€1.714+0.003+0.2%€1.714€1.714€1.7140
€1.711-0.01-0.6%€1.711€1.711€1.7110
€1.721-0.013-0.7%€1.721€1.721€1.7210
€1.734-0.067-3.7%€1.734€1.734€1.7340
€1.801+0.016+0.9%€1.801€1.801€1.8010
€1.785+0.04+2.3%€1.785€1.785€1.7850
€1.745+0.011+0.6%€1.745€1.745€1.7450
€1.734-0.014-0.8%€1.734€1.734€1.7340
€1.748-0.021-1.2%€1.748€1.748€1.7480
€1.769+0.039+2.3%€1.769€1.769€1.7690
€1.73+0.024+1.4%€1.73€1.73€1.730
€1.706-0.021-1.2%€1.706€1.706€1.7060
€1.727-0.001-0.1%€1.727€1.727€1.7270
€1.728+0.038+2.2%€1.728€1.728€1.7280
€1.69-0.014-0.8%€1.69€1.69€1.690
€1.704+0.004+0.2%€1.704€1.704€1.7040
€1.70-0.054-3.1%€1.70€1.70€1.700
€1.754+0.055+3.2%€1.754€1.754€1.7540
€1.699+0.006+0.4%€1.699€1.699€1.6990
€1.693-0.023-1.3%€1.693€1.693€1.6930
€1.716+0.029+1.7%€1.716€1.716€1.7160
€1.687+0.003+0.2%€1.687€1.687€1.6870
€1.684-0.017-1.0%€1.684€1.684€1.6840
€1.701+0.025+1.5%€1.701€1.701€1.7010
€1.676-0.024-1.4%€1.676€1.676€1.6760
€1.70+0.006+0.4%€1.70€1.70€1.700
€1.694-0.013-0.8%€1.694€1.694€1.6940
€1.707+0.026+1.5%€1.707€1.707€1.7070
€1.681-0.033-1.9%€1.681€1.681€1.6810
€1.714+0.005+0.3%€1.714€1.714€1.7140
€1.709-0.014-0.8%€1.709€1.709€1.7090
€1.723-0.018-1.0%€1.723€1.723€1.7230
€1.741+0.057+3.4%€1.741€1.741€1.7410
€1.684-0.028-1.6%€1.684€1.684€1.6840
€1.712-0.029-1.7%€1.712€1.712€1.7120
€1.741-0.024-1.4%€1.741€1.741€1.7410
€1.765-0.021-1.2%€1.765€1.765€1.7650
€1.786+0.05+2.9%€1.786€1.786€1.7860
€1.736+0.026+1.5%€1.736€1.736€1.7360
€1.71+0.033+2.0%€1.71€1.71€1.710
€1.677-0.002-0.1%€1.677€1.677€1.6770
€1.679-0.046-2.7%€1.679€1.679€1.6790
€1.725+0.027+1.6%€1.725€1.725€1.7250
€1.698-0.028-1.6%€1.698€1.698€1.6980
€1.726-0.01-0.6%€1.726€1.726€1.7260
€1.736+0.028+1.6%€1.736€1.736€1.7360
€1.708-0.022-1.3%€1.708€1.708€1.7080
€1.73+0.002+0.1%€1.73€1.73€1.730
€1.728+0.007+0.4%€1.728€1.728€1.7280
€1.721+0.049+2.9%€1.721€1.721€1.7210
€1.672+0.017+1.0%€1.672€1.672€1.6720
Ticker
Frankfurt:272
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Mabion SA news

Mabion SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
10 in the last 12 months · 18 in all · newest Aug 26, 2026 · oldest 2024
Decks
24 decks · latest Sep 15, 2026

Where Mabion SA is listed

ListingExchangeCountryCurrency
GPW:MAB · Home listingGPWPolandPLN
gettex:272gettexGermanyEUR
LSE:0QGWLSEUnited KingdomPLN
LS Exchange:A1J13QLS ExchangeGermanyEUR
Lang & Schwarz:A1J13QLang & SchwarzGermanyEUR
Stuttgart:272StuttgartGermanyEUR
Frankfurt:272 · This pageFrankfurtGermanyEUR
Munich:272MunichGermanyEUR

Valuation

EV/sales 9.7× against a median of 1.1×: the highest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
170.5M PLN
P/E
Loss
EV/sales
9.7×
EV/EBITDA
Negative EBITDA
Price/book
6.0×
Gross margin
−71.5%
Operating margin
−221.3%
Net margin
−321.4%
Debt to equity
1.3×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Mabion SA · GPW:MABUS$35.44MUS$42.01Mn/a9.7×n/a6.0×−321.4%1.3×n/a
Harvard Bioscience, Inc. · NASDAQ:HBIOUS$39.60MUS$71.90Mn/a0.8×28.4×7.8×−13.2%7.3×1.34
CytoGen, Inc. · KRX:217330US$38.59MUS$31.67Mn/a1.6×n/a1.6×−38.5%0.4×n/a
HUMASIS Co., Ltd. · KRX:205470US$37.49M−US$89.15Mn/a−3.8×n/a0.2×−49.2%0.0×n/a
IXICO PLC · LSE:IXIUS$37.27MUS$35.81Mn/a4.2×n/a2.7×−25.3%0.1×n/a
Trajan Group Holdings Ltd · ASX:TRJUS$34.94MUS$64.98Mn/a0.6×7.6×0.5×−0.4%0.6×n/a
Novacyt SAS · EURONEXT:ALNOVUS$33.87MUS$35.59Mn/a0.8×n/a1.4×−102.4%0.6×n/a
Rapid Micro Biosystems, Inc. · NASDAQ:RPIDUS$33.56MUS$46.06Mn/a1.3×n/a3.8×−138.2%2.2×1.41
Abnova Taiwan Corp. · TWSE:4133US$32.15MUS$20.35M23.6×1.9×13.4×0.8×13.0%0.0×n/a
Precipio, Inc. · NASDAQ:PRPOUS$31.11MUS$27.88Mn/a1.0×119×2.1×−4.1%0.0×1.00
Aligned Genetics, Inc. · KRX:238120US$31.02MUS$28.31M9.0×2.4×11.8×1.1×28.7%0.3×n/a
Median of the othersUS$34.41MUS$33.63M16.3×1.1×13.4×1.5×−19.2%0.3×1.34

Forecasts

Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
10.00 PLN · Analysts' mean
Revenue, year to Dec 2025
31.1M · 1 analyst

Team and board

Officers

OfficerRole
Dorota OwczarekDirector, Qualified Person
Paweł PobiedzińskiBusiness Development Director

Board

DirectorRole
Anna WieczorekDirector
Bartłomiej CzubekDirector
Edyta Bartusik-CzubekDirector
Ilona HinzDirector
Łukasz WaszakDirector
Marta BednarekDirector
PhD Anna Czubatka-BieńkowskaDirector
Tomasz KurpiewskiDirector

Events

QuarterResultsShare move
Q1 2026May 25, 2026 · Before open−1.2%
Q2 2025Sep 9, 2025 · Before open+0.9%
Q1 2025May 27, 2025 · Before open−1.2%
Q3 2024Nov 5, 2024 · After close−0.8%
Q2 2024Sep 10, 2024 · Before open−1.7%
Q1 2024May 14, 2024 · Before open−3.3%
Q3 2023Nov 14, 2023 · Before open+3.1%
Q2 2023Sep 12, 2023 · Before open+3.1%
Q1 2023Apr 22, 2023 · Before open−2.1%
Q3 2022Nov 24, 2022 · After close−6.6%
All 15 quarters
QuarterResultsShare move
Q2 2022Sep 30, 2022−0.8%
Q1 2022May 27, 2022 · Before open−4.0%
Q3 2021Nov 29, 2021 · After close−1.6%
Quarter to Jun 30, 2021Sep 16, 2021 · Before open+2.0%
Quarter to Mar 31, 2021May 20, 2021 · After close+12.3%

Open Events

Decks

DeckKindSlidesDate
H1 2026 Earnings PresentationEarnings15 slidesSep 15, 2026
Investor Presentation (June 2026)Investor deck29 slidesJune 2026
Investor Presentation (May 2026)Investor deck29 slidesMay 2026
FY2025 Earnings PresentationEarnings25 slidesApr 28, 2026
Investor Presentation (January 2026)Investor deck27 slidesJanuary 2026
Q3 2025 Earnings PresentationEarnings24 slidesDec 2, 2025
Investor Presentation (December 2025)Investor deck27 slidesDecember 2025
Q1 2024 Earnings PresentationEarnings21 slidesMay 14, 2024
FY2023 Earnings PresentationEarnings25 slidesApr 16, 2024
Investor Presentation (February 2024)Investor deck26 slidesFebruary 2024
All 24 decks
DeckKindSlidesDate
Q2 2023 Earnings PresentationEarnings19 slidesSep 12, 2023
Q1 2023 Earnings PresentationEarnings16 slidesMay 23, 2023
FY2022 Earnings PresentationEarnings60 slidesApr 18, 2023
Q3 2022 Earnings PresentationEarnings22 slidesNov 25, 2022
Q2 2022 Earnings PresentationEarnings20 slidesSep 30, 2022
Technical Presentation (November 2021)Technical24 slidesNov 25, 2021
Corporate Update (October 2021)Corporate update19 slidesOctober 2021
GPW Innovation Day 2021Conference20 slidesJune 2021
Investor Presentation (March 2021)Investor deck38 slidesMarch 2021
Corporate Update (October 2020)Corporate update24 slidesOct 30, 2020
Corporate Update (July 2020)Corporate update16 slidesJuly 2020
Investor Presentation (November 2019)Investor deck20 slidesNov 25, 2019
Investor Presentation (May 2018)Investor deck32 slidesMay 9, 2018
Konferencja WallStreet 2009Conference21 slidesJun 6, 2009

Open Decks

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue15.8M69.0M151.7M164.0M56.9M1.59M00
Cost of revenue33.2M27.9M37.1M98.0M21.0M9.83M466.0K797.0K971.0K758.0K
Gross profit-17.4M41.2M114.6M66.0M28.2M-9.83M-466.0K-797.0K-971.0K-758.0K
Research and development75.0K902.0K6.25M15.1M13.6M35.7M40.7M44.9M43.3M44.2M
Selling, general and administrative33.9M41.7M40.2M28.7M11.0M7.95M3.63M3.22M7.07M3.18M
Operating income-52.8M-7.57M55.1M28.2M-11.0M-56.4M-63.3M-64.6M-62.4M-55.5M
Depreciation and amortization9.09M8.70M7.20M8.98M8.85M9.83M11.1M10.7M8.04M6.94M
EBITDA-43.7M1.13M62.3M37.2M-2.12M-46.5M-52.2M-54.0M-54.3M-48.6M
Interest expense804.0K3.15M1.22M1.94M1.53M1.41M751.0K1.92M1.72M217.0K
Income before tax-62.6M-1.65M49.9M22.0M-10.3M-55.8M-63.7M-68.9M-57.9M-55.8M
Income tax4.68M8.63M-1.15M-12.2M-2.77M70.0K
Net income-62.6M-6.33M41.3M23.2M1.90M-57.2M-64.7M-68.9M-57.9M-55.8M
Earnings per share, basic-3.87-0.392.551.430.12-4.17-4.72-5.26-4.91-4.84

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents6.37M38.4M47.8M53.6M48.7M2.40M28.0M58.4M1.04M14.8M
Short-term investments108.0K
Receivables3.17M2.87M25.5M13.6M18.7M1.87M746.0K7.00K8.00K7.00K
Inventory1.41M2.70M7.75M10.3M8.45M6.75M8.81M10.3M7.16M4.23M
Current assets12.8M45.9M90.5M82.2M82.4M11.8M40.3M72.2M9.97M23.0M
Property, plant and equipment88.7M65.3M71.7M71.7M72.3M68.1M
Total assets110.4M159.5M208.3M186.2M184.2M78.3M113.5M144.7M82.4M91.2M
Accounts payable6.13M4.38M7.94M12.8M23.2M18.1M15.9M14.3M14.0M9.91M
Current liabilities43.9M39.1M55.3M74.3M96.1M104.6M86.4M66.5M120.4M73.5M
Long-term debt10.2M66.0K225.0K377.0K202.0K200.0K580.0K1.39M1.86M
Total debt12.7M4.61M35.8M7.28M20.4M36.7M21.9M5.64M66.0M12.7M
Total liabilities55.1M48.0M90.5M109.7M130.9M155.7M135.1M102.6M136.6M87.5M
Shareholders' equity48.8M111.4M117.8M76.5M53.3M-77.4M-21.6M42.1M-54.2M3.73M
Shares outstanding16.2M16.2M16.2M16.2M15.6M13.7M13.7M13.1M11.8M11.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-41.6M39.9M-2.33M38.8M-32.9M-35.2M-33.8M-38.9M-54.1M-15.2M
Capital spending-892.0K-12.3M-38.0M-16.7M-31.6M-3.36M-9.21M-6.85M-7.03M-2.49M
Free cash flow-42.5M26.3M-40.3M22.1M-64.5M-38.6M-43.0M-45.8M-61.2M-17.7M
Cash from investing-795.0K-12.3M-38.0M-16.1M-31.3M-3.00M-9.16M-6.77M-7.11M-2.49M
Cash from financing10.3M-36.9M34.5M-17.8M110.5M12.7M12.5M103.1M47.5M26.5M
Share buybacks1.00K-10.3M2.35M
Change in cash-32.1M-9.37M-5.82M4.93M46.3M-25.6M-30.4M57.4M-13.8M8.75M

Open Financials

Cap table

Built by 6ix from Mabion SA’s releases

Common shares
16,162,326
Fully diluted
16,162,326

Fully diluted

LineShares
Common shares16,162,326

Share count over time

CountShares
Nov 22, 202616,162,326

Open Cap table

Shareholders

HolderSharesValueChangeAs of
State Street(R) SPDR(R) Portfolio Europe ETF374US$742−9Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anna WieczorekDirector · Since at least Nov 5, 2026
Bartłomiej CzubekDirector · Since at least Nov 5, 2026
Dorota OwczarekDirector, Qualified Person · Since at least Nov 5, 2026
Edyta Bartusik-CzubekDirector · Since at least Nov 5, 2026
Ilona HinzDirector · Since at least Nov 5, 2026
Łukasz WaszakDirector · Since at least Nov 5, 2026
Marta BednarekDirector · Since at least Nov 5, 2026
Paweł PobiedzińskiBusiness Development Director · Since at least Nov 4, 2026
PhD Anna Czubatka-BieńkowskaDirector · Since at least Nov 5, 2026
Tomasz KurpiewskiDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Mabion SA.